Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZS76
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,623
Award facts
- Contract value 100% obligated
- $123,623.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $123,623.25 delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Entyvio 300 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. Entyvio (vedolizumab) is a biologic medication used to treat inflammatory bowel conditions, reflecting the company's specialization in providing branded pharmaceutical products to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's Special Pharmaceutical Enumerated (SPE2DB) program, which is valued at $499,999,999 and remains valid through November 2026. The SPE2DB vehicle enables the agency to procure a comprehensive range of pharmaceutical products, including biologics, prescription medications, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency to distribute essential medications and biologic therapies to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZS76?
SPE2DB25FZS76 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FZS76 worth?
The government has obligated $123,623 on SPE2DB25FZS76.
Is contract SPE2DB25FZS76 an order under another contract?
Yes. SPE2DB25FZS76 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS76 competed?
The extent of competition for SPE2DB25FZS76 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award